Aldeyra Therapeutics Inc (ALDX)
3.93
+0.02
(+0.51%)
USD |
NASDAQ |
Apr 24, 09:37
Aldeyra Therapeutics Cash from Investing (TTM): 30.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 30.00M |
September 30, 2023 | 57.00M |
June 30, 2023 | 76.02M |
March 31, 2023 | 58.08M |
December 31, 2022 | -29.95M |
September 30, 2022 | -56.95M |
June 30, 2022 | -75.97M |
March 31, 2022 | -58.03M |
December 31, 2021 | -0.0078M |
September 30, 2021 | -0.0078M |
June 30, 2021 | 5.492M |
March 31, 2021 | 22.79M |
December 31, 2020 | 29.02M |
September 30, 2020 | 24.74M |
June 30, 2020 | 24.91M |
March 31, 2020 | 15.54M |
December 31, 2019 | 18.48M |
September 30, 2019 | -6.210M |
June 30, 2019 | -11.91M |
March 31, 2019 | -18.97M |
Date | Value |
---|---|
December 31, 2018 | -23.34M |
September 30, 2018 | -2.473M |
June 30, 2018 | -6.080M |
March 31, 2018 | -6.288M |
December 31, 2017 | -10.20M |
September 30, 2017 | -0.7679M |
June 30, 2017 | 3.427M |
March 31, 2017 | 0.6755M |
December 31, 2016 | -0.2252M |
September 30, 2016 | -14.50M |
June 30, 2016 | -15.12M |
March 31, 2016 | -13.04M |
December 31, 2015 | -13.04M |
September 30, 2015 | -0.0941M |
June 30, 2015 | -0.0459M |
March 31, 2015 | -0.0155M |
December 31, 2014 | -0.0141M |
September 30, 2014 | -0.0061M |
June 30, 2014 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-75.97M
Minimum
Jun 2022
76.02M
Maximum
Jun 2023
6.475M
Average
15.54M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
AbbVie Inc | -2.009B |
United Therapeutics Corp | -719.60M |
Heron Therapeutics Inc | 18.00M |
Esperion Therapeutics Inc | 42.50M |
FibroGen Inc | 153.66M |